Your browser doesn't support javascript.
Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients
Egyptian Journal of Otolaryngology ; 39(1) (no pagination), 2023.
Artículo en Inglés | EMBASE | ID: covidwho-20242324
ABSTRACT

Background:

Mucormycosis is a serious life-threatening fungal infection that recently made severe sudden and devastating surge during the second wave of the COVID-19 epidemic with a mortality rate of up to 50%. Although the causality link between COVID-19 and rhino-orbito-cerebral mucormycosis (ROCM) remains unclear, many factors including poor diabetes control, high doses of steroids, viral-induced lymphopenia, and cytokine storm have been attributed to ROCM in patients with COVID-19. Orienting to risk factors and early recognition of this potentially fatal opportunistic infection is the key to optimal management and improved outcomes. In these contexts, we conducted a prospective study for 33 patients admitted to our tertiary hospital to determine the risk factors for ROCM in patients with COVID-19 and the cumulative mortality rates. Result(s) This study found a statistically significant relation between the fate of death in COVID-MUCOR patients who had presented fever, ophthalmoplegia, facial skin necrosis, and visual loss with those who received dose of steroid to control their respiratory symptoms P < 0.001. Death from COVID-MUCOR was statistically significant related to the prolonged interval from the onset of the symptoms to start of treatment and intervention. Also, it was found that there was a significant decrease in duration between COVID-19 infection and the start of mucormycosis (days) with incidence of DKA on admission. Nineteen (57.6%) of the patients had uncontrolled diabetes mellitus (hemoglobin A1C (HbA1c) of > 7.0%). Conclusion(s) Mucormycosis epidemic was precipitated by a unique confluence of risk factors diabetes mellitus, widespread use of steroids, and perhaps SARS-CoV-2 infection itself. Restricting steroid use in patients with severe COVID-19 requiring oxygen therapy, and screening for and optimally controlling hyperglycemia, can prevent COVID-MUCOR in a large majority.Copyright © 2023, The Author(s).
Palabras clave

Texto completo: Disponible Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Tipo de estudio: Estudio de cohorte / Estudio observacional / Estudio pronóstico Idioma: Inglés Revista: Egyptian Journal of Otolaryngology Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Tipo de estudio: Estudio de cohorte / Estudio observacional / Estudio pronóstico Idioma: Inglés Revista: Egyptian Journal of Otolaryngology Año: 2023 Tipo del documento: Artículo